Mounjaro vs Zepbound Telehealth Pricing: 2026 Brand and Compound Costs

Last reviewed: September 19, 2026 Last updated: September 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mounjaro and Zepbound are both FDA-approved tirzepatide injections—Mounjaro for type 2 diabetes, Zepbound for chronic weight management. Through telehealth, brand-name Mounjaro runs $1,249–$1,299 per month at Levity (captured September 4, 2026), and brand-name Zepbound starts at $299 per month for the lowest dose at Ro and LifeMD, rising to $449–$1,498 per month at higher doses or through other providers (captured September 4, 2026). Most platforms that offer brand-name access charge a separate membership—Ro's membership is $149 per month ($89/month on six-month prepaid, $74/month on annual prepaid), LifeMD's is $39 the first month then $149 per month, and PlushCare's is $19.99 per month or $149 per year after a 30-day free trial, plus a $129 self-pay visit fee (all captured September 4, 2026). Compounded tirzepatide injections, which are not FDA-approved, range from $149 per month at BrightMeds and AltRx (promotional rates captured September 4, 2026) to $399 per month at several providers; PlexusDx compounded tirzepatide injection is $289 per month on month-to-month, $269 per month on three-month prepaid (our calculation: $807 upfront), or $249 per month on six-month prepaid (our calculation: $1,494 upfront), all-inclusive with no membership or hidden fees.

Mounjaro vs Zepbound: At-a-glance comparison

Brand-name Mounjaro and Zepbound: Telehealth pricing and membership structure

Levity offers brand-name Mounjaro at $1,249 for the first month and $1,299 per month on refill, all-inclusive and billed approximately every four weeks (captured September 4, 2026). This is the only verified all-in Mounjaro price in our evidence set.

Zepbound pricing varies by provider and dose. Ro lists Zepbound at $299 per month for the starting dose, with higher doses running up to $449 per month, and requires a separate membership of $149 per month month-to-month, $89 per month on six-month prepaid (our calculation: $534 upfront), or $74 per month on annual prepaid (our calculation: $888 upfront); medication is charged separately (captured September 4, 2026). LifeMD follows a similar split: Zepbound medication starts at $299 per month at the lowest dose, with an introductory membership of $39 the first month then $149 per month ongoing; you can cancel anytime (captured September 4, 2026). OrderlyMeds charges $1,498 per month for a 28-day Zepbound pen supply, medication and program included (captured September 4, 2026).

PlushCare offers prescriptions for Mounjaro, Zepbound, and other FDA-approved GLP-1s sent to your pharmacy; the service charges a $129 self-pay visit fee plus a membership of $19.99 per month or $149 per year after a 30-day free trial; medication and labs are extra and filled through your chosen pharmacy (captured September 4, 2026). Form Health provides obesity-medicine physician and dietitian care with FDA-approved medication access only for $299 per month; labs and medications are separate (captured September 4, 2026).

Over 12 months, all-in brand Mounjaro at Levity totals approximately $15,548 (our calculation: first month $1,249 + eleven refills at $1,299 each). For Zepbound at Ro's starting dose with month-to-month membership, the 12-month total is approximately $5,376 (our calculation: twelve months of $299 medication + twelve months of $149 membership). LifeMD's structure yields approximately $4,926 over 12 months (our calculation: first month $299 medication + $39 membership, then eleven months of $299 medication + $149 membership).

Compounded tirzepatide: Telehealth pricing landscape

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Compounded tirzepatide pricing captured September 4 and September 19, 2026, spans a wide range. At the low end, BrightMeds advertises $357 for three months—$119 per month effective (our calculation)—or $149 per month month-to-month, all-inclusive at any dose (captured September 4, 2026). AltRx lists tirzepatide at $149 per month month-to-month, $144 per month on three-month prepaid (our calculation: $432 upfront), $130 per month on six-month prepaid (our calculation: $780 upfront), and $125 per month on twelve-month prepaid (our calculation: $1,500 upfront), all-inclusive (captured September 4, 2026); that promotion was stated to end September 5, 2026.

In the mid-tier, Mochi Health charges $90 per month for compounded tirzepatide at the starting dose plus an introductory membership of $39 per month—$129 total at the lowest dose; higher doses cost more (captured September 4, 2026). OrderlyMeds offers a tirzepatide starter rate of $149.50 per month effective on a two-month prepaid plan ($299 upfront), then $299 per month ongoing (captured September 4, 2026). ShedRx lists $299 per month month-to-month, $269 per month on six-month prepaid (our calculation: $1,614 upfront), and $239 per month on twelve-month prepaid (our calculation: $2,868 upfront), though pages contain conflicting teaser prices (captured September 4, 2026). Amble charges $289 per month for a lower-dose tier and $329 per month for a higher tier, with no advertised hidden or shipping fees (captured September 4, 2026). Found's cash-pay plan is $289 per month month-to-month or $169 per month on twelve-month prepaid (our calculation: $2,028 upfront); the insurance plan is $199 per month month-to-month or $99 per month on twelve-month prepaid (our calculation: $1,188 upfront), plus typical copay; compounded medication is included (captured September 4, 2026). Eden charges $199 per month for compounded tirzepatide medication plus a $99 per month membership after an introductory first month of $39—$298 total ongoing (captured September 4 and September 19, 2026).

At the higher end, MEDVi's compounded tirzepatide injection is $279 the first month (introductory rate) and $399 on refill, all-inclusive with clinician care and shipping, billed monthly with no contract and the ability to cancel anytime (checkout-verified, captured September 4, 2026). Embody and Peak Wellness each list $349 per month all-inclusive for tirzepatide with no membership; Peak offers lower per-month rates on six-month prepaid plans (checkout-verified, captured September 19, 2026). TrimRx advertises $349 per month but checkout-verified pricing is $399 per month month-to-month; prepaid plans of three, six, and twelve months lower the effective monthly rate (captured September 19, 2026). Fridays Health advertises $359 per month with multi-month subscriptions that lower the effective rate; prepaid details were not yet verified as of September 19, 2026. Willow starts at $399 per month all-in with free two-day shipping (captured September 4, 2026).

PlexusDx compounded tirzepatide injection is $289 per month month-to-month, $269 per month on three-month prepaid (our calculation: $807 upfront), or $249 per month on six-month prepaid (our calculation: $1,494 upfront). All tiers are all-inclusive: medication, online provider visit, prescription, and shipping, with no membership or hidden fees.

Normalized 12-month cost: Brand Mounjaro, brand Zepbound, and compounded tirzepatide

The table below compares annualized spending for representative brand and compounded tirzepatide options using verified month-to-month pricing where available. All multi-month figures are our calculation.

When prepaid discounts are factored in, some providers' effective monthly rates drop significantly. For example, PlexusDx compounded tirzepatide on six-month prepaid works out to $249 per month (our calculation: $1,494 upfront), or $2,988 over 12 months if renewed (our calculation). Found's cash-pay twelve-month prepaid is $169 per month effective ($2,028 upfront), and AltRx's twelve-month prepaid is $125 per month effective ($1,500 upfront); both captured September 4, 2026. Every prepaid figure should be confirmed at checkout; renewal terms and medication availability may change.

What drives the price difference between brand and compounded tirzepatide?

Brand-name Mounjaro and Zepbound are FDA-approved drugs manufactured under current Good Manufacturing Practice regulations, with established efficacy and safety data from large clinical trials. Eli Lilly sets the list price, and telehealth platforms negotiate acquisition cost, pass through fulfillment overhead, and layer on clinical service fees and profit margins. The result is a significantly higher retail price than compounded alternatives.

Compounded tirzepatide is prepared by licensed 503A pharmacies on a per-patient prescription basis. These products are not FDA-approved; FDA does not verify compounded drugs for safety, effectiveness, or quality before they reach patients. Compounding pharmacies source active pharmaceutical ingredients, reconstitute or prepare sterile injectables, and ship directly. Because compounded drugs bypass the branded-drug supply chain and regulatory approval pathway, their production cost is lower, and telehealth providers can offer them at prices that range from one-tenth to one-third of brand pricing. However, compounded drugs are not reviewed by FDA, and quality can vary across pharmacies. A licensed clinician determines whether a compounded prescription is appropriate for an individual patient.

Membership and unbundled fees: Hidden costs in brand-access programs

Several telehealth platforms that offer brand Zepbound or Mounjaro split the total cost into medication and membership or visit components. Ro charges $149 per month for its Body Program membership (or $89 per month on six-month prepaid, $74 per month on annual prepaid) and bills medication separately starting at $299 per month; over 12 months on the month-to-month plan, that membership alone adds $1,788 (our calculation) to the medication cost (captured September 4, 2026). LifeMD's membership is $39 the first month then $149 per month; over 12 months the membership total is $1,678 (our calculation: $39 + eleven months of $149), also billed separately from the $299-and-up medication cost (captured September 4, 2026).

PlushCare operates as a prescription-writing platform: it charges a $129 self-pay visit fee plus a $19.99 monthly membership (or $149 annual) after a 30-day free trial, then sends your prescription to a pharmacy of your choice; medication and labs are extra, filled and paid through that pharmacy (captured September 4, 2026). Form Health's $299 per month program fee covers physician and dietitian care but not the medication or labs (captured September 4, 2026). Hims & Hers and WeightWatchers Clinic also offer brand GLP-1 pathways; WeightWatchers Clinic advertises a promotional membership of $25 per month for the first two months on a twelve-month plan, then $74 per month, with medication generally charged separately (captured September 4, 2026).

In contrast, many compounded tirzepatide programs quote all-in pricing: PlexusDx, Levity, BrightMeds, Embody, Peak Wellness, Willow, OrderlyMeds (compounded tier), ShedRx, Amble, and MEDVi each include clinician visit, prescription, medication, and shipping in a single monthly fee with no separate membership. When comparing a brand program to a compounded one, add the membership or visit fee to the medication cost to find the true recurring monthly spend.

Strengths and gaps: Brand FDA approval vs compounded cost

Brand-name Mounjaro and Zepbound carry FDA approval, regulatory oversight, and the backing of large-scale clinical trials. Patients who prioritize that regulatory assurance, who have insurance that covers branded tirzepatide, or who are eligible for manufacturer copay-assistance programs may find the higher out-of-pocket cost justified. Insurance and prior-authorization pathways exist for both drugs, though coverage policies vary widely by plan. Telehealth platforms that facilitate brand access—particularly those that help with prior authorization and connect to major pharmacy networks—offer a streamlined experience for patients who qualify.

Compounded tirzepatide offers a materially lower out-of-pocket cost, often one-fifth to one-tenth of brand pricing, and does not require insurance or prior authorization. This accessibility makes it attractive to cash-pay patients and those whose insurance does not cover GLP-1 medications for weight management. However, compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality. Sterile compounding carries inherent contamination and potency risks, and quality control standards vary across 503A pharmacies. A licensed clinician determines whether a compounded prescription is appropriate, but the regulatory gap is a meaningful trade-off against the cost savings.

PlexusDx works with licensed 503A compounding pharmacies and publishes transparent pricing with no membership or hidden fees. We cannot guarantee uninterrupted supply or dose availability, and compounded medications are not FDA-approved substitutes for brand drugs.

Choose brand Mounjaro or Zepbound if…

• You have insurance that covers branded tirzepatide for weight management or type 2 diabetes and your out-of-pocket cost is manageable after prior authorization.
• You qualify for Eli Lilly's copay-assistance or patient-support programs.
• You prioritize FDA-approved medication with regulatory oversight and established clinical trial data.
• You are comfortable with the telehealth platform's membership or visit-fee structure and understand the total recurring monthly cost.
• Your clinician has specifically prescribed Mounjaro for type 2 diabetes or Zepbound for chronic weight management, and brand continuity is important to your treatment plan.

Choose compounded tirzepatide if…

• You are paying out-of-pocket and want a significantly lower monthly cost.
• Your insurance does not cover GLP-1 medications for weight management, or prior authorization has been denied.
• You understand that compounded drugs are not FDA-approved, that FDA does not review compounded medications for safety, effectiveness, or quality, and you accept the trade-off of lower regulatory oversight for lower cost.
• You prefer an all-in pricing model with no separate membership or visit fees.
• A licensed clinician has determined that compounded tirzepatide is appropriate for your individual situation.

Where PlexusDx compounded tirzepatide fits

PlexusDx compounded tirzepatide injection is $289 per month month-to-month, $269 per month on three-month prepaid (our calculation: $807 upfront), and $249 per month on six-month prepaid (our calculation: $1,494 upfront). Every tier is all-inclusive: online provider visit, prescription, medication, and shipping, with no membership, no per-visit charges, and no hidden fees. We work with licensed 503A compounding pharmacies; compounded medications are not FDA-approved, and FDA does not review them before marketing. A licensed clinician reviews your intake and determines whether a prescription is appropriate for you. We do not guarantee eligibility, dose availability, or uninterrupted supply.

PlexusDx also offers compounded tirzepatide in oral-capsule form at $349 per month month-to-month, $299 per month on three-month prepaid (our calculation: $897 upfront), and $279 per month on six-month prepaid (our calculation: $1,674 upfront), all-inclusive. Oral tirzepatide is compounded and not FDA-approved; absorption and efficacy data are limited compared to the injection.

Our pricing is competitive within the mid-tier of the compounded tirzepatide market. Providers such as BrightMeds and AltRx offer lower headline rates—sometimes promotional—while others charge $349–$399 per month or more. We publish standard ongoing pricing with transparent prepaid discounts and no artificial first-month teaser rates. You see the real recurring cost before you start.

Methodology and freshness

All pricing and program details in this article were captured from provider websites, checkout flows, or public plan grids between September 4, 2026, and September 19, 2026, and are cited with their capture date and evidence classification (primary-public, checkout-verified, or public grid). Brand-name Mounjaro pricing is from Levity's public grid (captured September 4, 2026). Brand-name Zepbound pricing is from Ro, LifeMD, and OrderlyMeds public pages and checkout flows (captured September 4, 2026). Compounded tirzepatide pricing is from provider sites and verified checkout sessions across fifteen telehealth platforms (captured September 4 and September 19, 2026). PlexusDx pricing reflects live product pages as of September 2026. Every multi-month cost total and effective per-month figure labeled "our calculation" was derived by multiplying the stated monthly rate by the number of months or dividing a prepaid total by the prepaid term; these are our calculations and not advertised figures. We do not publish competitor promotional codes or derive prices by discount arithmetic; every figure is captured directly or calculated transparently from captured components. Readers should confirm current pricing, membership terms, and medication availability at checkout before committing to any program.

Frequently Asked Questions

Are Mounjaro and Zepbound the same medication?

Yes, both contain the same active ingredient, tirzepatide, at identical dose strengths. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management. The pens, formulation, and mechanism are the same, but the indication and labeling differ.

Why is compounded tirzepatide so much cheaper than brand Mounjaro or Zepbound?

Compounded tirzepatide is prepared by licensed 503A pharmacies on a per-prescription basis, bypassing branded-drug pricing, marketing overhead, and the FDA approval pathway. Compounded medications are not FDA-approved; FDA does not review compounded drugs for safety, effectiveness, or quality, and production cost is lower, allowing telehealth providers to offer significantly reduced pricing.

Can I use insurance for telehealth Mounjaro or Zepbound prescriptions?

Some telehealth platforms facilitate prior authorization and send prescriptions to in-network pharmacies where your insurance may cover part of the cost, subject to your plan's formulary and medical-necessity criteria. Out-of-pocket costs vary widely; confirm coverage and copay with your insurer and the telehealth provider before starting treatment.

What is the real monthly cost of Zepbound through Ro or LifeMD?

At Ro, Zepbound medication starts at $299 per month for the lowest dose, plus a $149 per month membership (or lower on prepaid membership tiers)—$448 per month total on month-to-month. At LifeMD, it is $299 medication plus $39 the first month then $149 per month membership—$448 ongoing. Higher doses of Zepbound cost more. Confirm the combined total at checkout.

Does PlexusDx offer brand-name Mounjaro or Zepbound?

No. PlexusDx offers compounded tirzepatide injection and oral capsule through licensed 503A compounding pharmacies. Compounded medications are not FDA-approved and are not substitutes for brand-name drugs. A licensed clinician determines whether a compounded prescription is appropriate for you.

Sources

• PlexusDx internal verified pricing and commercial research archive (accessed September 19, 2026)
• Levity public plan grid, mounjaro and zepbound pricing (captured September 4, 2026)
• Ro Body Program public pages and membership tiers (captured September 4, 2026)
• LifeMD weight-management program pages (captured September 4, 2026)
• OrderlyMeds compounded and brand tirzepatide pricing (captured September 4, 2026)
• PlushCare membership and visit-fee structure (captured September 4, 2026)
• Form Health program pricing (captured September 4, 2026)
• Found cash-pay and insurance plan pricing (captured September 4, 2026)
• Henry Meds oral tirzepatide pages (captured September 19, 2026)
• Eden compounded tirzepatide and membership pricing (captured September 4 and September 19, 2026)
• Embody, Peak Wellness, TrimRx checkout-verified pricing (captured September 19, 2026)
• Mochi Health per-dose pricing (captured September 4, 2026)
• MEDVi compounded tirzepatide injection checkout-verified rates (captured September 4, 2026)
• Fridays Health advertised tirzepatide rate (captured September 19, 2026)
• ShedRx monthly and prepaid tirzepatide tiers (captured September 4, 2026)
• Amble compounded tirzepatide dose tiers (captured September 4, 2026)
• Willow all-in tirzepatide pricing (captured September 4, 2026)
• BrightMeds public plan grid (captured September 4, 2026)
• AltRx monthly and prepaid tirzepatide pricing (captured September 4, 2026)
• WeightWatchers Clinic Med+ program promotional membership (captured September 4, 2026)
• Hims & Hers branded GLP-1 product pages (captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.